DrugMapper
Browse
Therapeutic Area
CANCER (51)
CARDIOVASCULAR (45)
DENTISTRY (2)
DERMATOLOGY (31)
DIABETES DRUGS & ENDOCRINOLOGY (61)
EMERGENCY MEDICINE (3)
ENT (5)
EYE (23)
GASTROINTESTINAL (29)
HEMATOLOGY (23)
MUSCULOSKELETAL (28)
NEUROLOGY DRUGS & NERVOUS SYSTEM (50)
PEDIATRICS (27)
PHARMACOLOGY (8)
PREGNANCY AND GYNECOLOGY (30)
RESPIRATORY (42)
RHEUMATOLOGY (19)
OTHER (1482)
Therapeutic Indication
Adverse Reaction (System Organ Classification)
Mechanism of Action
Primary Target
Target Level
Level 1
Level 2
Level 3
Level 4
Level 5
Level 6
Active Pharmaceutical Ingredients (APIs)
Small Molecules
ProDrugs
Antibodies
CNS drugs
Metabolites
Search
Therapeutic Indication
Adverse Reaction (System Organ Classification)
Mechanism of Action
Target Sequence
Chemical Structure
Physicochemical Properties
Analyze
Networks
Chemical Similarity
Scaffold Similarity
KNIME workflow
Downloads
Web services
Bulk Downloads
About
DrugMapper FAQs
Data Sources
Contact Us
Display Options:
Drug type
Therapeutic Area
Route of administration
Mechanism of Action
Indication
Status
Total:
10647
BOTULISM ANTITOXIN BIVALENT (EQUINE) TYPES A AND B
1
Unknown
Investigational
Unknown
Unknown
Unknown
Unknown
BOTULISM ANTITOXIN BIVALENT (EQUINE) TYPES A AND B
×
Maximum Phase:
1
First Approval:
None
UNII:
Molecule Type:
Unknown
Molecular Formula:
Molecular Weight:
AlogP:
PSA:
HBD:
HBA:
#RotB:
Source:
PROFILNINE SD
1
Unknown
Investigational
Unknown
Unknown
Unknown
Unknown
PROFILNINE SD
×
Maximum Phase:
1
First Approval:
None
UNII:
Molecule Type:
Unknown
Molecular Formula:
Molecular Weight:
AlogP:
PSA:
HBD:
HBA:
#RotB:
Source:
BMS-962476
1
Unknown
Investigational
Unknown
Unknown
Atherosclerosis
Unknown
BMS-962476
×
Maximum Phase:
1
First Approval:
None
UNII:
OSI903EJOV
Molecule Type:
Unknown
Molecular Formula:
Molecular Weight:
AlogP:
PSA:
HBD:
HBA:
#RotB:
Source:
MAFOSFAMIDE
1
Small molecule
Investigational
Unknown
Unknown
Central Nervous System Neoplasms; Leukemia; Lymphoma; Meningeal Neoplasms
Unknown
MAFOSFAMIDE
×
Maximum Phase:
1
First Approval:
None
UNII:
5970HH9923
Molecule Type:
Small molecule
Molecular Formula:
C9H19Cl2N2O5PS2
Molecular Weight:
401.27
AlogP:
1.83
PSA:
95.94
HBD:
2.0
HBA:
#RotB:
9.0
Source:
BMS-188797
1
Small molecule
Investigational
Unknown
Unknown
Neoplasms
Unknown
BMS-188797
×
Maximum Phase:
1
First Approval:
None
UNII:
0HG7S0S581
Molecule Type:
Small molecule
Molecular Formula:
C47H51NO15
Molecular Weight:
869.92
AlogP:
3.96
PSA:
230.52
HBD:
4.0
HBA:
#RotB:
10.0
Source:
.ALPHA.-PYRROLIDINONONANOPHENONE
1
Small molecule
Investigational
Unknown
Unknown
Melanoma
Unknown
.ALPHA.-PYRROLIDINONONANOPHENONE
×
Maximum Phase:
1
First Approval:
None
UNII:
S3FKL8RY1D
Molecule Type:
Small molecule
Molecular Formula:
C19H29NO
Molecular Weight:
287.45
AlogP:
4.69
PSA:
20.31
HBD:
0.0
HBA:
#RotB:
9.0
Source:
USL-311
1
Small molecule
Investigational
Unknown
Unknown
Glioblastoma
Unknown
USL-311
×
Maximum Phase:
1
First Approval:
None
UNII:
2BTG5MX2Q2
Molecule Type:
Small molecule
Molecular Formula:
C24H34N6O
Molecular Weight:
422.58
AlogP:
3.11
PSA:
64.6
HBD:
1.0
HBA:
#RotB:
5.0
Source:
IOFOLASTAT
1
Small molecule
Investigational
Unknown
Unknown
Unknown
Unknown
IOFOLASTAT
×
Maximum Phase:
1
First Approval:
None
UNII:
9T6EBU5ER1
Molecule Type:
Small molecule
Molecular Formula:
C19H26IN3O7
Molecular Weight:
535.34
AlogP:
1.62
PSA:
165.06
HBD:
6.0
HBA:
#RotB:
14.0
Source:
NG-NITRO-L-ARGININE
1
Unknown
Investigational
Unknown
Unknown
Unknown
Unknown
NG-NITRO-L-ARGININE
×
Maximum Phase:
1
First Approval:
None
UNII:
Molecule Type:
Unknown
Molecular Formula:
Molecular Weight:
AlogP:
PSA:
HBD:
HBA:
#RotB:
Source:
BOTENSILIMAB
1
Antibody
Investigational
Unknown
Unknown
Neoplasms
Unknown
BOTENSILIMAB
×
Maximum Phase:
1
First Approval:
None
UNII:
None
Molecule Type:
Antibody
Molecular Formula:
Molecular Weight:
AlogP:
PSA:
HBD:
HBA:
#RotB:
Source:
GDC-0152
1
Protein
Investigational
Unknown
Unknown
Neoplasms
Unknown
GDC-0152
×
Maximum Phase:
1
First Approval:
None
UNII:
4KW1M48SHS
Molecule Type:
Protein
Molecular Formula:
C25H34N6O3S
Molecular Weight:
498.65
AlogP:
2.81
PSA:
116.32
HBD:
3.0
HBA:
#RotB:
8.0
Source:
MIRODENAFIL
1
Small molecule
Investigational
Unknown
Unknown
Unknown
Unknown
MIRODENAFIL
×
Maximum Phase:
1
First Approval:
None
UNII:
504G362H0H
Molecule Type:
Small molecule
Molecular Formula:
C26H37N5O5S
Molecular Weight:
531.68
AlogP:
2.45
PSA:
120.76
HBD:
2.0
HBA:
#RotB:
11.0
Source:
TB
1
Unknown
Investigational
Unknown
Unknown
Unknown
Unknown
TB
×
Maximum Phase:
1
First Approval:
None
UNII:
Molecule Type:
Unknown
Molecular Formula:
Molecular Weight:
AlogP:
PSA:
HBD:
HBA:
#RotB:
Source:
IMC-EB10
1
Antibody
Investigational
Unknown
Unknown
Leukemia, Myeloid
Tyrosine-protein kinase receptor FLT3 inhibitor
IMC-EB10
×
Maximum Phase:
1
First Approval:
None
UNII:
None
Molecule Type:
Antibody
Molecular Formula:
Molecular Weight:
AlogP:
PSA:
HBD:
HBA:
#RotB:
Source:
D6-25-HYDROXYVITAMIN D3
1
Small molecule
Investigational
Unknown
Unknown
Unknown
Unknown
D6-25-HYDROXYVITAMIN D3
×
Maximum Phase:
1
First Approval:
None
UNII:
378HY809HV
Molecule Type:
Small molecule
Molecular Formula:
C27H44O2
Molecular Weight:
406.68
AlogP:
6.73
PSA:
40.46
HBD:
2.0
HBA:
#RotB:
6.0
Source:
TRANSTORINE
1
Small molecule
Investigational
Unknown
Unknown
Unknown
Unknown
TRANSTORINE
×
Maximum Phase:
1
First Approval:
None
UNII:
H030S2S85J
Molecule Type:
Small molecule
Molecular Formula:
C10H7NO3
Molecular Weight:
189.17
AlogP:
1.23
PSA:
70.16
HBD:
2.0
HBA:
#RotB:
1.0
Source:
EM-1421
1
Small molecule
Investigational
Unknown
Unknown
Unknown
Unknown
EM-1421
×
Maximum Phase:
1
First Approval:
None
UNII:
Molecule Type:
Small molecule
Molecular Formula:
Molecular Weight:
AlogP:
PSA:
HBD:
HBA:
#RotB:
Source:
OBP-801
1
Small molecule
Investigational
Unknown
Unknown
Neoplasms
Unknown
OBP-801
×
Maximum Phase:
1
First Approval:
None
UNII:
30Q3VS5HZ4
Molecule Type:
Small molecule
Molecular Formula:
C20H31N3O6S2
Molecular Weight:
473.62
AlogP:
0.52
PSA:
133.83
HBD:
4.0
HBA:
#RotB:
1.0
Source:
BMS-791826
1
Small molecule
Investigational
Unknown
Unknown
Unknown
Unknown
BMS-791826
×
Maximum Phase:
1
First Approval:
None
UNII:
60BN6CDL0K
Molecule Type:
Small molecule
Molecular Formula:
C28H26FN5O3S
Molecular Weight:
531.61
AlogP:
5.73
PSA:
97.31
HBD:
1.0
HBA:
#RotB:
6.0
Source:
TRODUSQUEMINE
1
Small molecule
Investigational
Unknown
Unknown
Obesity
Unknown
TRODUSQUEMINE
×
Maximum Phase:
1
First Approval:
None
UNII:
KKC12PIF16
Molecule Type:
Small molecule
Molecular Formula:
C37H72N4O5S
Molecular Weight:
685.07
AlogP:
5.53
PSA:
145.94
HBD:
6.0
HBA:
#RotB:
20.0
Source:
BIIF 1149 BS
1
Small molecule
Investigational
Unknown
Unknown
Unknown
Unknown
BIIF 1149 BS
×
Maximum Phase:
1
First Approval:
None
UNII:
Molecule Type:
Small molecule
Molecular Formula:
Molecular Weight:
AlogP:
PSA:
HBD:
HBA:
#RotB:
Source:
XL-888
1
Small molecule
Investigational
Unknown
Unknown
Melanoma; Neoplasms; Skin Neoplasms
Unknown
XL-888
×
Maximum Phase:
1
First Approval:
None
UNII:
7M346920EV
Molecule Type:
Small molecule
Molecular Formula:
C29H37N5O3
Molecular Weight:
503.65
AlogP:
4.22
PSA:
117.42
HBD:
3.0
HBA:
#RotB:
9.0
Source:
LETRAZURIL
1
Small molecule
Investigational
Unknown
Unknown
Unknown
Unknown
LETRAZURIL
×
Maximum Phase:
1
First Approval:
None
UNII:
U8736VCB22
Molecule Type:
Small molecule
Molecular Formula:
C17H9Cl2FN4O2
Molecular Weight:
391.19
AlogP:
3.02
PSA:
91.54
HBD:
1.0
HBA:
#RotB:
3.0
Source:
GSK2981278
1
Small molecule
Investigational
Unknown
Unknown
Psoriasis
Unknown
GSK2981278
×
Maximum Phase:
1
First Approval:
None
UNII:
L49V5G013I
Molecule Type:
Small molecule
Molecular Formula:
C25H35NO5S
Molecular Weight:
461.62
AlogP:
4.4
PSA:
76.07
HBD:
1.0
HBA:
#RotB:
10.0
Source:
ATIPAMEZOLE
1
Small molecule
Investigational
Unknown
Unknown
Unknown
Unknown
ATIPAMEZOLE
×
Maximum Phase:
1
First Approval:
None
UNII:
03N9U5JAF6
Molecule Type:
Small molecule
Molecular Formula:
C14H16N2
Molecular Weight:
212.3
AlogP:
2.86
PSA:
28.68
HBD:
1.0
HBA:
#RotB:
2.0
Source:
BEXMARILIMAB
1
Antibody
Investigational
Unknown
Unknown
Neoplasms
Unknown
BEXMARILIMAB
×
Maximum Phase:
1
First Approval:
None
UNII:
None
Molecule Type:
Antibody
Molecular Formula:
Molecular Weight:
AlogP:
PSA:
HBD:
HBA:
#RotB:
Source:
LODAPOLIMAB
1
Antibody
Investigational
Unknown
Unknown
Breast Neoplasms; Melanoma; Neoplasms; Pancreatic Neoplasms
Unknown
LODAPOLIMAB
×
Maximum Phase:
1
First Approval:
None
UNII:
NR4MAD6PPB
Molecule Type:
Antibody
Molecular Formula:
Molecular Weight:
AlogP:
PSA:
HBD:
HBA:
#RotB:
Source:
PF-04418948
1
Small molecule
Investigational
Unknown
Unknown
Unknown
Unknown
PF-04418948
×
Maximum Phase:
1
First Approval:
None
UNII:
I7Z38E70VF
Molecule Type:
Small molecule
Molecular Formula:
C23H20FNO5
Molecular Weight:
409.41
AlogP:
3.59
PSA:
76.07
HBD:
1.0
HBA:
#RotB:
6.0
Source:
AZD5312
1
Unknown
Investigational
Unknown
Unknown
Unknown
Unknown
AZD5312
×
Maximum Phase:
1
First Approval:
None
UNII:
Molecule Type:
Unknown
Molecular Formula:
Molecular Weight:
AlogP:
PSA:
HBD:
HBA:
#RotB:
Source:
CXB722
1
Small molecule
Investigational
Unknown
Unknown
Unknown
Unknown
CXB722
×
Maximum Phase:
1
First Approval:
None
UNII:
Molecule Type:
Small molecule
Molecular Formula:
Molecular Weight:
AlogP:
PSA:
HBD:
HBA:
#RotB:
Source:
ANSOFAXINE
1
Small molecule
Investigational
Unknown
Unknown
Unknown
Unknown
ANSOFAXINE
×
Maximum Phase:
1
First Approval:
None
UNII:
Molecule Type:
Small molecule
Molecular Formula:
Molecular Weight:
AlogP:
PSA:
HBD:
HBA:
#RotB:
Source:
LUXEPTINIB
1
Small molecule
Investigational
Unknown
Unknown
Leukemia, Lymphocytic, Chronic, B-Cell; Leukemia, Myeloid, Acute
Unknown
LUXEPTINIB
×
Maximum Phase:
1
First Approval:
None
UNII:
TQ6PBX1JU0
Molecule Type:
Small molecule
Molecular Formula:
C25H17F4N5O2
Molecular Weight:
495.44
AlogP:
5.5
PSA:
98.91
HBD:
4.0
HBA:
#RotB:
4.0
Source:
SONIFILAN
1
Unknown
Investigational
Unknown
Unknown
Unknown
Unknown
SONIFILAN
×
Maximum Phase:
1
First Approval:
None
UNII:
Molecule Type:
Unknown
Molecular Formula:
Molecular Weight:
AlogP:
PSA:
HBD:
HBA:
#RotB:
Source:
PFK-158
1
Small molecule
Investigational
Unknown
Unknown
Neoplasms
Unknown
PFK-158
×
Maximum Phase:
1
First Approval:
None
UNII:
2HOK1JQ203
Molecule Type:
Small molecule
Molecular Formula:
C18H11F3N2O
Molecular Weight:
328.29
AlogP:
4.54
PSA:
42.85
HBD:
0.0
HBA:
#RotB:
3.0
Source:
ACHN-975
1
Small molecule
Investigational
Unknown
Unknown
Unknown
Unknown
ACHN-975
×
Maximum Phase:
1
First Approval:
None
UNII:
48CET2EN53
Molecule Type:
Small molecule
Molecular Formula:
C20H23N3O4
Molecular Weight:
369.42
AlogP:
0.01
PSA:
124.68
HBD:
5.0
HBA:
#RotB:
5.0
Source:
1
2
…
99
100
101
102
103
104
105
…
304
305
Next »
Download Option
Close
Header
Compound Name
Maximum Phase
Compound Structure
Smile
Inchi
InchiKey
Compound Properties
Molecular Formula
Molecular Weight
ALogP
PSA